Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients. | Clin Res Cardiol | 2023 | 37410163 | PubTator, text mining | PubMed |
| Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: an epidemiological and genome-wide association study. | J Transl Med | 2023 | 37403158 | PubTator, text mining | PubMed |
| Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure. | Curr Heart Fail Rep | 2023 | 37402108 | PubTator, text mining | PubMed |
| Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus. | Lipids Health Dis | 2023 | 37400794 | PubTator, text mining | PubMed |
| Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages. | Nat Commun | 2023 | 37400454 | PubTator, text mining | PubMed |
| Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study. | BMJ Open | 2023 | 37400234 | PubTator, text mining | PubMed |
| Non-alcoholic fatty liver disease-related hepatocellular carcinoma. | J Liver Cancer | 2023 | 37384032 | PubTator, text mining | PubMed |
| Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study. | BMC Gastroenterol | 2023 | 37380950 | PubTator, text mining | PubMed |
| Survey of Dietary Habits and Physical Activity in Japanese Patients with Non-Obese Non-Alcoholic Fatty Liver Disease. | Nutrients | 2023 | 37375668 | PubTator, text mining | PubMed |
| Food Network Analysis in Non-Obese Patients with or without Steatosis. | Nutrients | 2023 | 37375618 | PubTator, text mining | PubMed |
| The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women. | Nutrients | 2023 | 37375574 | PubTator, text mining | PubMed |
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials. | Medicina (Kaunas) | 2023 | 37374340 | PubTator, text mining | PubMed |
| Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes. | Hum Mol Genet | 2023 | 37369012 | PubTator, text mining | PubMed |
| Metabolic-Associated Fatty Liver Disease and Insulin Resistance: A Review of Complex Interlinks. | Metabolites | 2023 | 37367914 | PubTator, text mining | PubMed |
| Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. | Cardiovasc Res | 2023 | 37364164 | PubTator, text mining | PubMed |
| A multisociety Delphi consensus statement on new fatty liver disease nomenclature. | Hepatology | 2023 | 37363821 | PubTator, text mining | PubMed |
| Prospects of evolution-based artificial intelligence models in genome-wide studies to stratify genetic risk variants in nonalcoholic fatty liver disease. | Ann Med Surg (Lond) | 2023 | 37363524 | PubTator, text mining | PubMed |
| Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets. | Front Endocrinol (Lausanne) | 2023 | 37361533 | PubTator, text mining | PubMed |
| The impact of CYP2C19 genotype on phenoconversion by concomitant medication. | Front Pharmacol | 2023 | 37361233 | PubTator, text mining | PubMed |
| Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality. | JAMA Netw Open | 2023 | 37358849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=36